StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3056% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 43.8Yield 5.61%

Pfizer Restructuring charges by Year

Restructuring charges — Employee termination costs ($M) ($M)

Pfizer Restructuring charges: $684M in FY2025, down 40.6% from a year earlier.

Latest, FY2025
684
Period ended Dec 31, 2025
Change on a year earlier
-40.6%
1,152 in FY2024
History
11 years
Since FY2015
Sources
10
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-Q / 10-K Note 3 — Restructuring Charges & Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRestructuring charges — Employee termination costs ($M) ($M)Year on yearSource
FY2025Dec 31, 2025684-40.6%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 20241,152-29.0%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 20231,622+109.0%Form 10-K (filed 2025-02-27) ↗
FY2022Dec 31, 2022776+14.1%Form 10-K (filed 2024-02-22) ↗
FY2021Dec 31, 2021680+43.5%Form 10-K (filed 2023-02-23) ↗
FY2020Dec 31, 2020474+338.9%Form 10-K (filed 2022-02-24) ↗
FY2019Dec 31, 2019108-76.5%Form 10-K (filed 2021-02-25) ↗
FY2018Dec 31, 2018459-353.6%Form 10-K (filed 2020-02-27) ↗
FY2017Dec 31, 2017-181-119.3%Form 10-K (filed 2019-02-28) ↗
FY2016Dec 31, 2016940+92.2%Form 10-K (filed 2018-02-22) ↗
FY2015Dec 31, 2015489–Form 10-K (filed 2017-02-23) ↗

Cite this data

StockData. (2026). Pfizer Restructuring charges ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/restruct-chg-sev

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?